Powell Investment Advisors’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-60,000
Closed -$23K 148
2022
Q2
$23K Buy
+60,000
New +$23K 0.01% 138
2022
Q1
Sell
-64,000
Closed -$156K 144
2021
Q4
$156K Buy
64,000
+21,000
+49% +$51.2K 0.09% 108
2021
Q3
$229K Buy
+43,000
New +$229K 0.14% 92